ライフサイエンスコーパス: primary hyperparathyroidism

1 initial localization study for patients with primary hyperparathyroidism.

2 rathyroidectomy is the preferred therapy for primary hyperparathyroidism.

3 ement resulted in an excellent cure rate for primary hyperparathyroidism.

4 treatment option in geriatric patients with primary hyperparathyroidism.

5 omen with asymptomatic or mildly symptomatic primary hyperparathyroidism.

6 oid hormone response, as is typical of human primary hyperparathyroidism.

7 tinues to be the only effective treatment of primary hyperparathyroidism.

8 e may significantly change the management of primary hyperparathyroidism.

9 id tumors is tantamount to the discussion of primary hyperparathyroidism.

10 bilateral neck exploration for patients with primary hyperparathyroidism.

11 All 40 patients were cured of primary hyperparathyroidism.

12 e procedure of choice for most patients with primary hyperparathyroidism.

13 vably provide a specific medical therapy for primary hyperparathyroidism.

14 rgery is the usual therapy for patients with primary hyperparathyroidism.

15 g R-568 in 20 postmenopausal women with mild primary hyperparathyroidism.

16 concentrations in postmenopausal women with primary hyperparathyroidism.

17 more than a year and had no cause other than primary hyperparathyroidism.

18 Parathyroid carcinoma is a rare cause for primary hyperparathyroidism.

19 ion of parathyroid adenomas in patients with primary hyperparathyroidism.

20 thyroid adenomas after failed procedures for primary hyperparathyroidism.

21 tive or additional tool in the evaluation of primary hyperparathyroidism.

22 ated with a decreased surgical cure rate for primary hyperparathyroidism.

23 elective venous sampling (SVS) in persistent primary hyperparathyroidism.

24 ts undergoing parathyroidectomy for sporadic primary hyperparathyroidism.

25 rd approach to the majority of patients with primary hyperparathyroidism.

26 complications, with a particular emphasis on primary hyperparathyroidism.

27 tions, even in individuals with asymptomatic primary hyperparathyroidism.

28 parathyroidectomy in patients with sporadic primary hyperparathyroidism.

29 l surgical approaches for many patients with primary hyperparathyroidism.

30 d for the majority of patients with sporadic primary hyperparathyroidism.

31 oidism, is recommended for all children with primary hyperparathyroidism.

32 consecutive patients undergoing surgery for primary hyperparathyroidism.

33 abnormal parathyroid glands in patients with primary hyperparathyroidism.

34 tion of parathyroid lesions in patients with primary hyperparathyroidism.

35 octogenarian and nonagenarian patients with primary hyperparathyroidism.

36 e and for treatment of certain patients with primary hyperparathyroidism.

37 ognitive changes often seen in patients with primary hyperparathyroidism.

38 090 patients were evaluated and explored for primary hyperparathyroidism.

39 hed by the 2002 NIH workshop on asymptomatic primary hyperparathyroidism.

40 s in serum calcium and PTH concentrations in primary hyperparathyroidism.

41 oid adenomas or hyperplasia in patients with primary hyperparathyroidism.

42 success of limited neck exploration (LE) for primary hyperparathyroidism (1 degrees HPT).

43 nagement regarding the care of patients with primary hyperparathyroidism (1 degrees HPTH) has evolved

44 riods of up to 10 years in 121 patients with primary hyperparathyroidism, 101 (83 percent) of whom we

45 nts undergoing initial parathyroidectomy for primary hyperparathyroidism (2002-2014).

46 cal notes were reviewed in 143 patients with primary hyperparathyroidism (35 men, 108 women; median a

47 Primary hyperparathyroidism, a disorder in which there i

48 Elderly patients with primary hyperparathyroidism accompanied by other disease

49 roid carcinoma is an extremely rare cause of primary hyperparathyroidism, accounting for fewer than 1

50 od, 17 patients were referred for persistent primary hyperparathyroidism after undergoing at least on

51 The most common etiologies are primary hyperparathyroidism and cancer.

52 ly recognized to be present in patients with primary hyperparathyroidism and critical for bone recons

53 years; range, 58-82 years) with biochemical primary hyperparathyroidism and inconclusive results at

54 Forty-eight consecutive patients with primary hyperparathyroidism and indications for surgery

55 9m)Tc-sestamibi performs well in complicated primary hyperparathyroidism and is recommended as first-

56 ntigraphy was performed on 110 patients with primary hyperparathyroidism and no prior neck surgery.

57 g repeat surgery for persistent or recurrent primary hyperparathyroidism and one patient with multipl

58 Failure to diagnose primary hyperparathyroidism and refer patients to surgeo

59 currently being tested for the treatment of primary hyperparathyroidism, and CaR-based therapeutics

60 more patients now present with asymptomatic primary hyperparathyroidism, and consensus guidelines ha

61 idneys and is seen in phosphate nephropathy, primary hyperparathyroidism, and distal renal tubular ac

62 and mortality are increased in patients with primary hyperparathyroidism, and might be predicted by p

63 on nontraditional symptoms in patients with primary hyperparathyroidism, and open the door to the co

64 easingly important role in the evaluation of primary hyperparathyroidism, and surgical referral may b

65 tive symptoms and conditions associated with primary hyperparathyroidism as well as postoperative imp

66 ve patients undergoing parathyroidectomy for primary hyperparathyroidism at a tertiary referral cente

67 e merits of medical and surgical therapy for primary hyperparathyroidism; based on measurements of qu

68 nesota, who received an initial diagnosis of primary hyperparathyroidism between 1965 and 1992 were i

69 y consecutive patients underwent surgery for primary hyperparathyroidism by a single surgeon between

70 Primary hyperparathyroidism can be cured by removal of t

71 Primary hyperparathyroidism can be cured by surgical rem

72 by the intrinsic 15% rate of multiglandular primary hyperparathyroidism, combined with the imperfect

73 eased in patients undergoing reoperation for primary hyperparathyroidism compared with initial proced

74 ve patients undergoing parathyroidectomy for primary hyperparathyroidism due to parathyroid hyperplas

75 of performing imaging before any surgery for primary hyperparathyroidism, even in the case of convent

76 ctioning parathyroid tissue in patients with primary hyperparathyroidism has been a longstanding diag

77 Another variant of primary hyperparathyroidism has been described in which

78 rathyroids, and intraoperative management of primary hyperparathyroidism has been observed over the p

79 Most patients with primary hyperparathyroidism have a single adenoma that w

80 Clinical guidelines for the treatment of primary hyperparathyroidism have been established by the

81 ation and intraoperative PTH assay (QPTH) in primary hyperparathyroidism have been established.

82 In the United States, most patients with primary hyperparathyroidism have few or no symptoms.

83 %-40% of patients after curative surgery for primary hyperparathyroidism (HPT) have an elevated parat

84 Primary hyperparathyroidism (HPT) in multiple endocrine

85 be a precursor of the classic hypercalcemic primary hyperparathyroidism (HPT).

86 ing the procedure of choice in patients with primary hyperparathyroidism (HPT).

87 Traditional surgery for primary hyperparathyroidism (HPTH) involves bilateral ce

88 athic hypercalciuria was diagnosed in 15.6%, primary hyperparathyroidism in 1.6%, and normocalcemic h

89 The NIH Consensus Conference on primary hyperparathyroidism in 1990 defined criteria for

90 era), the age- and sex-adjusted incidence of primary hyperparathyroidism in Rochester was 15 cases pe

91 led to a sharp increase in the incidence of primary hyperparathyroidism in the early 1970s.

92 They were, however, virtually absent in primary hyperparathyroidism, in which the transition bet

93 ticle reviews the diagnosis and treatment of primary hyperparathyroidism, including recent literature

94 linical changes and presentation of sporadic primary hyperparathyroidism, including the assessment of

95 Primary hyperparathyroidism is a common disorder with an

96 Primary hyperparathyroidism is a common endocrine disord

97 Primary hyperparathyroidism is a common endocrine disord

98 Primary hyperparathyroidism is a frequent and potentiall

99 Primary hyperparathyroidism is an endocrine disorder cha

100 Remedial surgery for primary hyperparathyroidism is challenging and requires

101 Almost always, primary hyperparathyroidism is due to a benign overgrowt

102 Primary hyperparathyroidism is generally discovered when

103 Primary hyperparathyroidism is rare and due to an adenom

104 Although the cause of primary hyperparathyroidism is still poorly understood,

105 Primary hyperparathyroidism is the most common cause of

106 Although primary hyperparathyroidism is the most common cause of

107 Primary hyperparathyroidism is the third most common end

108 The progressive decrease in the incidence of primary hyperparathyroidism is unexpected and suggests a

109 cular outcomes in patients with asymptomatic primary hyperparathyroidism is unproven, but data sugges

110 tional treatment for adults with symptomatic primary hyperparathyroidism, is recommended for all chil

111 ciuric hypercalcaemia (FHH), neonatal severe primary hyperparathyroidism (NSHPT) or autosomal dominan

112 continued study of the endocrine effects of primary hyperparathyroidism on brain function.

113 One hundred seventy-three patients with primary hyperparathyroidism operated on by a single surg

114 patients who had no known family history of primary hyperparathyroidism or the HPT-JT syndrome at pr

115 In patients with primary hyperparathyroidism, parathyroidectomy results i

116 bone mineral density (BMD) in patients with primary hyperparathyroidism (pHPT) and compare those res

117 Parathyroid adenomas (PAs) causing primary hyperparathyroidism (PHPT) are histologically he

118 or minimally invasive parathyroidectomy for primary hyperparathyroidism (pHPT) depends on the succes

119 Importance: Primary hyperparathyroidism (pHPT) is a common clinical

120 Primary hyperparathyroidism (pHPT) is a common clinical

121 Primary hyperparathyroidism (PHPT) is a common endocrine

122 Symptomatic primary hyperparathyroidism (PHPT) is associated with in

123 l and medical treatments on fracture risk in primary hyperparathyroidism (PHPT) is unknown.

124 ognitive changes are common in patients with primary hyperparathyroidism (pHPT), but the associations

125 During parathyroidectomy for primary hyperparathyroidism (PHPT), discovering a minima

126 n 4-gland parathyroid exploration (OPTX) for primary hyperparathyroidism (pHPT).

127 g (ADL), in older patients with asymptomatic primary hyperparathyroidism (PHPT).

128 ally invasive parathyroidectomy (MIP) due to primary hyperparathyroidism (primary HPTH).

129 Thus, this animal model of human primary hyperparathyroidism provides direct experimental

130 s of 130 consecutive remedial operations for primary hyperparathyroidism selectively used minimally i

131 All patients with primary hyperparathyroidism should undergo localization

132 evolution of surgical management of sporadic primary hyperparathyroidism (SPHPT).

133 glands during parathyroidectomy for sporadic primary hyperparathyroidism (SPHPT).

134 screening tests are not common, symptomatic primary hyperparathyroidism tends to predominate.

135 as neurophysiologic imaging in patients with primary hyperparathyroidism undergoing parathyroidectomy

136 Consecutive patients with primary hyperparathyroidism undergoing preoperative 4D-C

137 tal of 61 consecutive surgical patients with primary hyperparathyroidism underwent both (123)I/(99m)T

138 Symptoms were more common in patients with primary hyperparathyroidism versus thyroid controls, but

139 and positive predictive value of BIJ PTH for primary hyperparathyroidism were 80% and 71%, respective

140 A total of 114 consecutive patients with primary hyperparathyroidism were included from January 8

141 cutive patients with a clinical diagnosis of primary hyperparathyroidism were included in the study.

142 year period, 1368 parathyroid operations for primary hyperparathyroidism were performed at our instit

143 ases of initial neck surgery for nonfamilial primary hyperparathyroidism were selected for analysis.

144 Twenty-one consecutive patients with primary hyperparathyroidism were studied prospectively b

145 Since 1993, 291 consecutive patients with primary hyperparathyroidism were treated with "limited"

146 chnique resulted in excellent cure rates for primary hyperparathyroidism while simultaneously decreas

147 Records of 462 patients with primary hyperparathyroidism who underwent preoperative i

148 Forty patients with documented primary hyperparathyroidism who underwent surgery by a s

149 liminary fashion the brains of patients with primary hyperparathyroidism with functional imaging stud

150 approach for the treatment of patients with primary hyperparathyroidism with image-localized, presum

151 ive patients underwent parathyroidectomy for primary hyperparathyroidism with ioPTH monitoring.